Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Prospective Randomized Study of Accelerated Radiation Therapy (PRART)

See Locations Near You

Summary

Patients with Stage 0 ductal carcinoma in situ (Tis (DCIS), Stage T1-T2, lymph node negative(N0) breast cancers will be randomized to receive whole breast radiotherapy with a concomitant boost to the tumor bed over 15 fractions (Arm 1, standard) versus 10 fractions (Arm 2, experimental).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women status post segmental mastectomy
If unilateral, pT1-2 breast cancer excised with negative margins
If bilateral, pT1-2 breast cancer excised with negative margins AND/OR pTis excised with negative margins.
Clinically N0 or pN0 or sentinel node negative
Ductal carcinoma in situ DCIS with negative margins (no DCIS on inked margins).

Exclusion Criteria:

Previous radiation therapy to the ipsilateral breast.
90 days from last surgery, unless s/p adjuvant chemotherapy
60 days from last chemotherapy
Male breast cancer

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

400

Study ID:

NCT04175210

Recruitment Status:

Recruiting

Sponsor:

Weill Medical College of Cornell University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

New York Presbyterian Hospital at Lower Manhattan Cancer Center
New York New York, 10007, United States More Info
Charles Ekeh, M.D.
Contact
646-962-2196
[email protected]
Pragya Yadav, Ph.D.
Contact
6469622199
[email protected]
Silvia Formenti, M.D.
Principal Investigator
Brooklyn Methodist Hospital - NewYork Presbyterian
New York New York, 11215, United States More Info
Izael Nino
Contact
[email protected]
Pragya Yadav, Ph.D.
Contact
6469622199
[email protected]
Hani Ashamalla, M.D.
Principal Investigator
New York Presbyterian Hospital - Queens
New York New York, 11355, United States More Info
Sarah Stankiewich, B.S.
Contact
718-661-7246
[email protected]
Pragya Yadav, Ph.D
Contact
6469622199
[email protected]
Akkamma Ravi, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

400

Study ID:

NCT04175210

Recruitment Status:

Recruiting

Sponsor:


Weill Medical College of Cornell University

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider